Literature DB >> 12144130

CD138.

J Wijdenes1, J M Dore, C Clement, C Vermot-Desroches.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12144130

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN： 0393-974X            Impact factor:   1.711


× No keyword cloud information.
  7 in total

1.  Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.

Authors:  Yoshio Jinno; Haruo Ohtani; Shiro Nakamura; Motoji Oki; Kiyoshi Maeda; Kohei Fukushima; Hiroshi Nagura; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Virchows Arch       Date:  2006-01-25       Impact factor: 4.064

2.  Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone.

Authors:  Priya Jeyaraj; Manu Venkatesan; V S Nijhawan
Journal:  J Maxillofac Oral Surg       Date:  2015-01-30

3.  Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.

Authors:  Caroline Rousseau; Ludovic Ferrer; Stéphane Supiot; Manuel Bardiès; François Davodeau; Alain Faivre-Chauvet; Pierre Baumgartner; John Wijdenes; Marie Lacombe; Jacques Barbet; Thierry Guillaume; Philippe Moreau; Jean Luc Harousseau; Françoise Kraeber-Bodéré; Michel Cherel
Journal:  Tumour Biol       Date:  2012-03-03

4.  Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.

Authors:  Hua Jiang; Wenhao Zhang; Peipei Shang; Hui Zhang; Weijun Fu; Fei Ye; Tianmei Zeng; Hejing Huang; Xueguang Zhang; Wanping Sun; Daniel Man-Yuen Sze; Qing Yi; Jian Hou
Journal:  Mol Oncol       Date:  2013-12-12       Impact factor: 6.603

5.  Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.

Authors:  Peter Herbener; Kurt Schönfeld; Martin König; Matthias Germer; Jude M Przyborski; Katrin Bernöster; Jörg Schüttrumpf
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

6.  Expression Profile of Stemness Markers CD138, Nestin and Alpha-SMA in Ameloblastic Tumours.

Authors:  Callisthenis Yiannis; Massimo Mascolo; Michele Davide Mignogna; Silvia Varricchio; Valentina Natella; Gaetano De Rosa; Roberto Lo Giudice; Cosimo Galletti; Rita Paolini; Antonio Celentano
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

7.  Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.

Authors:  Marie-Christine Kyrtsonis; Vassiliki Bartzis; Xenophon Papanikolaou; Efstathios Koulieris; George Georgiou; Maria Dimou; Tatiana Tzenou; Panayiotis Panayiotidis
Journal:  Appl Clin Genet       Date:  2010-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.